Article thumbnail

Aripiprazole monotherapy in patients with rapid-cycling bipolar I disorder: an analysis from a long-term, double-blind, placebo-controlled study

By D J Muzina, C Momah, J M Eudicone, A Pikalov, R D McQuade, R N Marcus, R Sanchez and B X Carlson
Topics: Original Articles
Publisher: Blackwell Publishing Ltd
OAI identifier: oai:pubmedcentral.nih.gov:2324208
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2005). A 20-month, doubleblind, maintenance trial of lithium versus divalproex in rapidcycling bipolar disorder.
  2. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder.
  3. (2003). A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry
  4. (2003). A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania.
  5. (2007). Adequacy of treatment received by diagnosed and undiagnosed patients with bipolar I and II disorders.
  6. (2004). Altar CA. In vivo effects of aripiprazole on cortical and striatal dopaminergic and serotonergic function.
  7. (2006). Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study.
  8. (2007). Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, doubleblind study versus placebo.
  9. (2008). Aripiprazole monotherapy in patients with rapid-cycling bipolar I disorder ª 2008 The Authors Journal compilation ª
  10. (2002). Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors. J Pharmacol Exp Ther
  11. (2003). Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology. Neuropsychopharmacology
  12. (2003). Bipolar disorder, obesity, and pharmacotherapy-associated weight gain.
  13. (2001). Bipolar rapid cycling: focus on depression as its hallmark.
  14. (1991). Clozapine prophylaxis in rapid cycling bipolar disorder.
  15. (2004). Comparison of rapid-cycling and non-rapid-cycling bipolar I manic patients during treatment with olanzapine: analysis of pooled data.
  16. (2005). Effectiveness of aripiprazole vs. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial.
  17. (2005). Impact of misdiagnosis in dual diagnosis rapid cycling bipolar disorder. Bipolar Disord
  18. (2007). Interaction of the novel antipsychotic aripiprazole with 5-HT(1A) and 5-HT (2A) receptors: functional receptor-binding and in vivo electrophysiological studies. Psychopharmacology (Berl)
  19. (2004). Mood state at study entry as predictor of the polarity of relapse in bipolar disorder. Biol Psychiatry
  20. (2005). New data on the use of lithium, divalproate, and lamotrigine in rapid cycling bipolar disorder. Eur Psychiatry
  21. (2003). Obesity as a correlate of outcome in patients with bipolar I disorder.
  22. (2003). Olanzapine in the acute treatment of bipolar I disorder with a history of rapid cycling.
  23. (2004). Phenomenology of rapid-cycling bipolar disorder: data from the first 500 participants in the Systematic Treatment Enhancement Program.
  24. (2002). Prevalence of obesity and weight change during treatment in patients with bipolar I disorder.
  25. (2002). Quetiapine in the treatment of rapid cycling bipolar disorder. Bipolar Disord
  26. (2007). Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study. Bipolar Disord
  27. (2006). Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine.
  28. (2005). Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: post hoc analyses of 47-week data.
  29. (2006). Rapid-cycling bipolar disorder: reviewing the evidence for pharmacologic interventions.
  30. (2004). Response to clozapine of rapid cycling versus non-cycling patients with a history of mania. Bipolar Disord
  31. (2002). The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT(1A) receptor.
  32. (2003). The long-term course of rapid-cycling bipolar disorder. Arch Gen Psychiatry
  33. (2002). Treatment of bipolar I rapid cycling patients during dysphoric mania with olanzapine.
  34. (2006). Treatment of rapid-cycling bipolar disorder.
  35. (1998). Treatment of refractory rapid cycling bipolar disorder with risperidone.